What is the normal reference range for adenosine deaminase (ADA) activity in serum/plasma and in pleural fluid?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Values of Adenosine Deaminase

There is no single "normal" reference range for adenosine deaminase (ADA) because the test is measured in different body fluids with different diagnostic thresholds, and serum ADA should not be used for tuberculosis diagnosis. 1, 2

Serum ADA Reference Ranges

  • Serum ADA1: Upper limit 7.2 U/L 3
  • Serum ADA2: Upper limit 14.6 U/L 3
  • Total serum ADA in healthy donors: Mean 16.5 ± 3.18 U/L 4

Critical Caveat About Serum ADA

Never rely on serum ADA for tuberculosis diagnosis—it lacks specificity and is elevated in hepatitis, infectious mononucleosis, pneumonia, rheumatoid arthritis, empyema, and malignancy. 2 The British Thoracic Society and American College of Chest Physicians explicitly recommend measuring ADA in the appropriate body fluid (pleural, pericardial, peritoneal, or CSF) rather than serum. 2

Body Fluid ADA Diagnostic Thresholds

These are not "normal values" but rather diagnostic cutoffs to distinguish tuberculous from non-tuberculous disease:

Pleural Fluid

  • Diagnostic threshold: 40 U/L 1
  • Sensitivity: 76-90%, Specificity: 77-100% for tuberculous pleurisy 2
  • Alternative threshold of 30 U/L yields 94% sensitivity and 95% specificity 5
  • Values below 40 U/L generally exclude tuberculosis 1

Cerebrospinal Fluid (CSF)

  • Diagnostic threshold: 9-10 U/L 6, 1
  • Sensitivity: 79%, Specificity: 91% at this threshold 6, 1
  • Values <4 U/L: Exclude tuberculosis with >93% sensitivity but <80% specificity 6, 1
  • Values >8 U/L: Strongly suggest tuberculosis with >96% specificity but <59% sensitivity 6, 1

Peritoneal (Ascitic) Fluid

  • Diagnostic threshold: 32-40 U/L in patients without cirrhosis 1
  • Sensitivity: 100%, Specificity: 96.6-100% 1
  • Lower threshold of 27-32 U/L in patients with cirrhosis 1
  • Sensitivity: 91.7-100%, Specificity: 92-93.3% in cirrhotic patients 1

Pericardial Fluid

  • Diagnostic threshold: 40 U/L 1
  • Sensitivity: 88%, Specificity: 83% 6, 1

Critical Clinical Pitfalls

ADA Does Not Provide Definitive Diagnosis

ADA levels provide only supportive evidence and must be interpreted within the complete clinical context—they cannot definitively diagnose tuberculosis. 6, 1

False Positives

Empyema can elevate ADA above tuberculous thresholds (>40-47 U/L), creating a critical diagnostic pitfall. 7 To distinguish empyema from tuberculous pleurisy:

  • Perform bench centrifugation: empyema leaves clear supernatant, tuberculous effusions remain milky 7
  • Check pleural fluid glucose: empyema has significantly lower glucose (47.3 ± 25.3 mg/dL) versus non-infectious effusions (102.5 ± 35.6 mg/dL) 7
  • Examine neutrophil predominance: bacterial effusions show 69 ± 23% neutrophils, while tuberculous effusions show lymphocyte predominance 7
  • Send cultures for both bacteria AND tuberculosis simultaneously 7

HIV and Immunocompromised Patients

In HIV-infected patients, ADA concentrations may remain low even when tuberculosis is present, reducing test reliability. 2 However, one study found ADA remains sensitive (94%) even in patients with CD4 counts <50 cells/μL, with no correlation between ADA values and CD4 counts. 5

ADA Isoenzyme Analysis

High total ADA in tuberculous effusions is due mainly to ADA-2 (originating from monocytes/macrophages), not ADA-1. 8 Using combined criteria (ADA >47 U/L, ADA-2 >40 U/L, and 2'-deoxyadenosine deaminase/ADA ratio <0.49) achieves 100% sensitivity and 97% specificity for tuberculous pleurisy. 8

References

Guideline

Diagnostic Thresholds for Adenosine Deaminase (ADA) in Various Body Fluids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

ADA Testing in Body Fluids for Tuberculosis Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

ADA Elevation in Empyema Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.